Effect of nebulizer configuration on delivery of aerosolized tobramycin

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 10, Issue 1, 1997, Pages 13-23

  O'Riordan, Thomas G ^a   Amram, Jose C ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

aerosolized antibiotics; aerosolized drug delivery; cystic fibrosis

Indexed keywords

TECHNETIUM 99M; TOBRAMYCIN;

AEROSOL; ARTICLE; DRUG DELIVERY SYSTEM; ENVIRONMENTAL FACTOR; NEBULIZATION; NEBULIZER; PARTICLE SIZE;

EID: 0030936482     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1997.10.13     Document Type: Article

References (18)

1. Ramsey, B.W., H.L. Dorkin, J.D. Eisenberg, R. Gibson, I.R. Harwood, R.M. Kravitz, D.V. Schidlow, R.W. Wilmott, S.J. Astley, M.A. McBurrne, K. Wentz, and A.L. Smith. 1993. Efficacy of tobramycin in patients with cystic fibrosis. N. Engl. J. Med 328:1740-1746.
2. Hodson, M.E. 1989. Antibiotic treatment. Aerosol therapy. Chest 94:1568-1628.
3. Smaldone, G.G., R.J. Perry, and D.G. Deutsch. 1988. Characteristics of nebulizers used in the treatment of AIDS-related Pneumocystis carinii pneumonia. J. Aerosol Med. 1:113-126.
4. O'Riordan, T.G., M. Greco, and G.C. Smaldone. 1992. Nebulizer function during mechanical ventilation. Am. Rev. Respir. Dis. 145:1117-1222.
5. Newman, S.P., G. Woodman, and S.W. Clarke. 1988. Deposition of carbenicillin aerosols in cystic fibrosis. Effect of nebulizer system and breathing pattern. Thorax 43:318-312.
6. Smaldone, G.C., J. Fuhrer, R. Steigbigel, and M. McPeck. 1991. Factors determining pulmonary deposition of aerosolized pentamidine in patients with human immunodeficiency virus infection. Am. Rev. Respir. Dis. 143:727-737.
7. O'Riordan, T.G., L.B. Palmer, and G.C. Smaldone. 1994. Aerosol deposition in mechanically ventilated patients: Optimizing nebulizer delivery. Am. J. Respir. Crit. Care Med. 149:214-219.
8. Mason, J.W., W.C. Miller, and S. Small. 1994. Comparison of aerosol delivery via Circulaire system versus conventional small volume nebulizer. Respiratory Care 39:1157-1161.
9. Smaldone, G.C. 1991. Drug delivery via aerosol systems: Concept of "aerosol inhaled." J. Aerosol Med. 4:229-236.
10. Zar, J.H. 1974. Biostatistical Analysis. Prentice-Hall, Inc., Englewood Cliffs, NJ, 105-107.
11. Godfrey, K. 1985. Comparing the means of several groups. N. Engl. J. Med. 313:1450-1456.
12. Agnew, J. 1984. Physical properties and mechanisms of deposition of aerosols. In S. Clarke and D. Pavia, eds. Aerosols and the Lung: Clinical and Experimental Aspects. Butterworth, London, 49-70.
13. Bennett, W.D. 1991. Aerosolized drug delivery: Fractional deposition of inhaled particles. J. Aerosol Med. 4:223-229.
14. Rowite, J.S., J.D. Gorvoy, and G.C. Smaldone. 1987. Quantitative deposition of aerosolized gentamicin in cystic fibrosis. Am. Rev. Respir. Dis. 136:1445-1449.
15. Groth, M.L., G.C. Smaldone, C. Patel, and J. DeCelle-Germana. 1993. Deposition and clearance of aerosolized gentamicin in cystic fibrosis. Am. Rev. Respir. Dis. 147:A26.
16. Weber, A., A. Smith, J. Williams-Warren, B. Ramsey, and D. Civert. 1994. Nebulizer delivery of tobramycin to the lower respiratory tract. Pediatr. Pulmonol. 17:331-339.
17. Marshall, L.M., P.W. Francis, and F.A. Khafagi. 1994. Aerosol deposition in cystic fibrosis using an aerosol conservation device and a conventional jet nebulizer. J. Pediatr. Child Health. 30:65-67.
18. O'Riordan, T.G. and G.C. Smaldone. 1992. Exposure of health care workers to aerosolized pentamidine. Chest 101:1494-1499.